Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Eksterne analyser

Generic: Strong growth, temporarily lower profitability - ABG

Generic Sweden

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.

Download analyse (PDF)
26% organic sales growth y-o-y
Growth initiatives hurt profitability mid-term
Pricing to act as a tailwind for gross margin in Q3


Q2: Sales growth of 26%, EBIT margin of 15.5% (20%)

There was a similar trend in Generic's Q2 numbers as we saw in Q1, where sales growth was impressive but opex growth was also higher than we have seen traditionally. The company reported net sales of SEK 43.4m (+26% y-o-y, all organic), and EBIT was SEK 6.7m (6.9m). This was 4% above our expectations on sales but 9% below on EBIT. The sales growth was driven partly by existing customers and partly by new agreements being signed. The deviation vs. our EBIT forecast was partly because of a lower than expected gross margin and partly because of higher opex. Price initiatives helped to improve the gross margin q-o-q and we will probably see a further tailwind in Q3 as the price adjustments were made in the middle of the quarter.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.